Pseudomonas aeruginosa poses a serious threat in healthcare settings. This bacterium can develop resistance to many antibiotics, rendering even last-resort treatments ineffective. Additionally, it forms protective biofilms that shield it from the immune system, making infection treatment challenging. This study investigated the susceptibility of five clinically isolated strains of the test bacteria to a combination of ciprofloxacin and cuminaldehyde. Cuminaldehyde (a natural phytochemical) and ciprofloxacin (an antibiotic) were separately found to show antimicrobial effect against test organism. However, the combination of selected compounds showed an additive effect in their microbial growth inhibitory activity. The mentioned compounds at their sub-MIC doses subjected to test whether they could show any extent of biofilm inhibition or disintegration property against the clinical strains of P. aeruginosa. The chosen concentrations of the compounds demonstrated significant antibiofilm activity against all the tested clinical strains. Additionally, it was observed that the compounds not only accumulated reactive oxygen species (ROS) but also enhanced the cell membrane permeability of the clinical strains. These findings suggest that the combination of ciprofloxacin and cuminaldehyde could explore new directions in fighting P. aeruginosa-linked infections.